MedTrace Logo

Measure of Acceptance of chRonic Visible sKin conditionS

NCT06103903 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-10-27

No results posted yet for this study

Summary

The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with a large number of patients (children, adolescents, adults) and their parents (depending on the composition of the family cluster), in a multicentric manner (for territorial representativeness).

Conditions

  • Acceptance of Visible Chronic Dermatological Disease
  • Disease Acceptance
  • Psychological Well-Being
  • Social Segregation

Interventions

BEHAVIORAL

Questionnaire

Questionnaire according to age (6-13;14-17); the parents for minors and adults

Sponsors & Collaborators

  • INSERM UMR 1246 SPHERE

    collaborator UNKNOWN

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Annabel MARUANI, MD-PhD · University Hospital of TOURS

  • Jean-Benoit HARDOUIN, MD-PhD · INSERM UMR 1246 SPHERE

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06103903 on ClinicalTrials.gov